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Abstract
Background: Streptococcus agalactiae (Group B Streptococcus, GBS), a leading cause of sepsis and meningitis in
infants, can be transmitted vertically from mother to infant during passage through the birth canal. Detection of
GBS colonization in perinatal women is a major strategy for the prevention of postpartum neonatal disease. The U.
S. Centers for Disease Control and Prevention recommends that all women undergo vaginal-rectal screening for
GBS colonization at 35-37 weeks of gestation. ChromID Strepto B (STRB) is a chromogenic GBS screening media on
which GBS colonies appear pink or red, while other bacteria are either inhibited or form colonies in other colors. In
this study, we compared STRB with a conventional GBS detection method using 5% sheep blood agar (BA) followed
by a selective enrichment broth.
Methods: Anovaginal swabs were collected from 1425 women during weeks 35 to 37 of their pregnancies. The
swabs were used to inoculate both STRB and BA plates after enrichment with selective Todd Hewitt Broth (THB).
A GBS latex agglutination test was used to confirm the identity of isolates from each plate.
Results: GBS was recovered from 319 (22.4%) samples with one or both media: 318 on STRB compared to 299
using BA. One false negative was observed on STRB, and 20 false negatives were observed on BA. In addition,
non-hemolytic GBS was recovered from 19 (6.0%) samples using STRB.
Conclusions: STRB offers effectiveness and convenience over BA for GBS screening in clinical laboratories. STRB
produces fewer false negatives, has a higher detection rate and uses a simple color screen that is ideal for
technician-level applications. We recommend STRB as the media of choice for GBS screening.
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Background
Streptococcus agalactiae (Group B Streptococcus, GBS)
is a leading cause of sepsis and meningitis in infants.
GBS can be transmitted vertically from mother to infant
during passage through the birth canal. Transmission is
thought to occur just before or during birth when GBS
ascends the genital tract into the amniotic fluid, where it
is aspirated or ingested by the infant [1]. Colonization
occurs in 3.2-24.3% of pregnant women [2-4]. Prior to
2011, the incidence of early-onset (< 7 days after birth)
GBS disease was 0.34-0.37 cases per 1000 births [5], with
22.6% of cases resulting in death or sequelae [6]. In
2011, the U.S. Centers for Disease Control and Preven-
tion (CDC) reported that the incidence of early-onset
GBS disease had declined from 1.7 cases per 1000 live
births to 0.34-0.37 cases per 1000 live births during the
15 years since the release of prevention guidelines (up-
dated in 2002) [5]. The guidelines recommend perinatal
screening of all pregnant women for carriage of GBS at
35-37 weeks of gestation. Vaginal/rectal swabs should be
inoculated into a selective broth medium, to aid the re-
covery of GBS, and incubated 18-24 hours before sub-
culturing on sheep blood agar plates or chromogenic
agar [5]. The “Guidelines for obstetrical practice in Japan
2011 edition” also recommend that all pregnant women
be screened by vaginal/rectal swabs at 33-37 weeks [7],
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ChromID Strepto B (STRB) is a chromogenic agar that
was developed to screen for GBS in pregnant women.
Using samples from 1425 Japanese women, we evaluated
STRB for ease of use and detection rate compared to
conventional blood agar. In addition, the occurrence and
detection of non-hemolytic GBS was evaluated. To our
knowledge, this is the first evaluation of STRB for a large
population of Japanese women.
Methods
Study design and population
This study was approved by the research ethics commit-
tee (Number 264, October 2010) of the Japanese Red
Cross Medical Center, Hiroo, Japan. The research ethics
committee granted exemption for this study, so that the
need for informed consent was waived. Between November
2010 and October 2011, an anovaginal swab was collected
from each of 1425 pregnant women at 35-37 weeks of ges-
tation. Sysmex Corporation contributed reagents to the
Japanese Red Cross Medical Center.
Collection and culture of specimens
All specimens were collected using sterile cotton swabs
that were submerged in Todd-Hewitt Broth supple-
mented with 100,000 U/L colistin and 15 mg/L nalidixic
acid (THB, Nikken Bio Medical Laboratory). Anovaginal
sampling was carried out by rotating a cotton swab
against the vaginal wall, then gently rotating the swab to
touch the anal crypts. Routine screening of pregnant
women for Streptococcus agalactiae (GBS) is always per-
formed during the prenatal consultation between 35 and
37 weeks of gestation. All samples were collected by a
physician and transported to the Laboratory of Bacteri-
ology Research within two hours. These swabs were
taken as part of standard patient care.
The samples were cultured following the CDC recom-
mendations. THB was inoculated with the swab and in-
cubated aerobically at 35°C for 18-24 hours. An aliquot
(10 μl) of each enriched THB culture was sub-cultured
on chromID Strepto B (STRB, bioMerieux, Marcy
l’Etoile, France) and 5% sheep blood agar (BA) plates
BBL, BD Diagnostics, Sparks, MD). Both media were in-
cubated at 35°C for 24 hours either aerobically (STRB)
or in 5% CO2 (BA). The plates were examined for pre-
sumptive positives, which were defined as: 1) pale pink
to red colonies on STRB (Figure 1A), or 2) white col-
onies with moist or glistening features and a narrow
zone of β-hemolysis (or no hemolysis) on BA (Figure 1B).
The BA isolates were used directly in a latex agglutination
assay (Prolex Streptococcal Grouping Latex kit, Iwaki,
Tokyo, Japan) for GBS identification, whereas the isolates
on STRB were first sub-cultured on BA before confirming
using latex agglutination (Seroiden Strepto Kit ‘EIKEN’,
Eiken Chemical, Tokyo, Japan). The colonies displaying
colors other than pink/red were identified using colony
characteristics, biochemical reactions, or a combination of
these tests. The two different media were assessed by two
different institutions in blind tests. GBS on BA was assessed
in a hospital, and GBS on STRB was observed by an exter-
nal clinical laboratory (SRL, Tokyo, Japan). All assessments
were performed at each institution by well-trained staff
members who were blinded to the results of the other.
Results
Of the 1425 samples, a total of 319 (22.4%) were positive
by at least one of the two media: 318 (22.3%) GBS iso-
lates were recovered from STRB and 299 (21.0%) were
recovered from BA. Although STRB recovered more
GBS-positive isolates, it produced fewer false negatives,
with only one compared to 20 for BA. Non-GBS col-
onies on STRB, displaying colors other than pink/red,
were identified as Enterococcus spp., Streptococcus spp.,
coagulase negative Staphylococcus spp., Corynebacterium
spp., and Lactobacillus spp. Of the 19 (6.0%) non-
hemolytic GBS isolates, 13 were recovered from GBS-
positive samples on both STRB and BA and six from
GBS-positive samples only on STRB. None of the non-
hemolytic GBS isolates grew on BA only.
Discussion
One of the most important requirements for a screening
protocol is the minimization of false negatives which, in
this case, can produce a high risk of neonatal GBS infec-
tion. Blood agar is widely used around the world for the
culture of hemolytic Group B Streptococci (GBS). Two
or more species of bacteria in recto-vaginal samples can
make detection of GBS difficult. In our study, only one
positive result that was missed following the 24-hour in-
cubation on STRB eventually displayed pink colonies
upon a 48-hour incubation. This result shows a trend
that is similar to other studies. Tazi et al. [8] and Robin
et al. [9] found that both media have a sensitivity of
100% following a 48- to 72-hour incubation after enrich-
ment. Although Aila et al. [10] also reported 100% sensi-
tivity for STRB, blood agar was much lower at 78% after
24-hour post-enrichment incubations. A comparison of
detection rates indicates that STRB is a good medium
with better sensitivity than that of BA.
In addition to the detection rate, the STRB detection
mechanism confers three additional benefits. The first
advantage is the easy visual identification of GBS com-
pared with blood agar, even when the specimen contains
a low level of GBS or when GBS in mixed with other mi-
croorganisms. Bacteria other than GBS display different
colors or are inhibited by antibiotics. Therefore, GBS
stands out against background flora (Figure 1C, D).
The second advantage is the detection of non-
hemolytic GBS. Non-hemolytic and non-pigmented GBS
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strains have been isolated from pregnant women at a
level ranging from 1 to 4% [11-17]. Tazi et al. [8] found
that non-hemolytic and non-pigmented strains are re-
sponsible for meningitis and sepsis in newborns.
Miranda et al. [18] also reported that non-hemolytic
GBS can cause endocarditis. Because these reports sug-
gest that infection with non-hemolytic GBS can cause
neonatal GBS disease, non-hemolytic colonies must also
be tested for the presence of GBS. STRB can identify
non-hemolytic GBS with the same simple color scheme
that is used for hemolytic strains. In this study, of the
319 GBS isolates, 19 were non-hemolytic. Among the 20
false negatives on BA plates were 6 non-hemolytic GBS
samples. These data indicate that STRB is more suited
than BA for the detection of non-hemolytic GBS strains.
The third advantage is that STRB plates are incubated
in an aerobic environment, whereas BA is generally in-
cubated in 5% CO2.
Although the positive rate of the STRB screen is excel-
lent, there are some disadvantages. Streptococcus porci-
nus and Streptococcus anginosus give false positive
results on STRB [8,10]. We also found few Enterococcus
spp. and Streptococcus spp. strains on STRB in this study
(no statistical data). The target organisms are characterized
by enzyme systems that metabolize the substrate to release
the chromogen, which enables the organisms to display a
typical color. STRB includes three chromogenic sub-
strates, and three enzymes (phosphatase, esterase and
β-cellobiosidase) react with these substrates such that the
color of the organisms results from the combination of
these three substrates. Each substrate gives a pink, blue,
and purple color for phosphatase activity, esterase activity,
and β-cellobiosidase activity, respectively. GBS are colored
by only one of these three substrates, and thus show only
one color. On the other hand, other species are colored by
one to three enzymatic reactions so that various color
combinations and variable colors can be seen. A given oc-
currence or enzymatic activity for each substrate can differ
between organisms. In our study, some Streptococcus spp.
other than GBS and Enterococcus spp. strains showed pink
colonies, while others showed blue, white and purple col-
onies. Enterococcus spp. and Streptococcus spp. on STRB
was sub-cultured on blood agar. Enterococcus spp. was
identified by Gram stain, 6.5% NaCl, bile esculin and EF
agar. Streptococcus spp. was identified by Gram stain, 6.5%
NaCl, bile esculin, EF agar, hemolysis and Optochin test.
Because false positives are a possibility, an additional con-
firmatory test using a biochemical or immunological assay,
as recommended by the manufacturer, should be per-
formed on each isolate. STRB contains light-sensitive
components and should not be exposed to light except
when necessary during the inoculation and reading steps.
A B
DC
Figure 1 STRB and BA plates after a 24-hours incubation. Streptococcus agalactiae (GBS) on STRB (A) and blood agar (BA) plates (B);
Enterococcus faecalis and GBS on STRB (C) and BA (D). Pink colonies = GBS; Blue colonies = E. faecalis.
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These precautions may make the test more complicated
for laboratory technicians.
BA is a non-selective conventional agar [19]. The ab-
sence of antibiotics in the media allows most organisms
to grow easily, especially gram positive organisms, since
the growth of gram negative organisms is inhibited dur-
ing enrichment. Therefore, large numbers of non-GBS
organisms may make it difficult to isolate GBS, especially
if those organisms produce large β-hemolytic zones. In
this study, the 20 false negatives obtained on BA grew as
small colonies on STRB or were mixed with organisms
that had large β-hemolytic zones. A greater level of ex-
pertise is needed to identify GBS on BA from character-
istics alone, increasing the possibility of variability in
interpretation between technicians.
Conclusions
The detection rate of STRB with enrichment was higher
than BA with enrichment. Moreover, STRB has the ad-
vantages of easy detection and decreased risk of variabil-
ity in interpretation. STRB is also particularly useful for
the detection of non-hemolytic GBS colonies. Extending
incubation time past 24 hours decreases the likelihood
of identifying false negatives.
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